JMP Securities Initiates Coverage on Rapport Therapeutics (NASDAQ:RAPP)

JMP Securities assumed coverage on shares of Rapport Therapeutics (NASDAQ:RAPP – Free Report) in a research note issued to investors on Tuesday morning,Benzinga reports. The brokerage issued a market outperform rating and a $28.00 target price on the stock. Separately, Citizens Jmp initiated coverage on shares of Rapport Therapeutics in a research report on Tuesday. […]